Abiopharma

Dyadic Announces Second Quarter 2026 Financial Results Accelerating Commercialization Momentum Across Key Business Areas

VEONs Banglalink Receives Bangladesh Bank Approval to Launch Digital Payment Service Mukto Pay

Victory Marine Holdings’ DGBH Appoints Miles Bodie Director of E-Commerce to Lead Next Phase of GUTSI™ Omnichannel Growth

Propanc Biopharma Highlights Differentiated Proenzyme Therapy PRP as a Potential Therapy of Choice Against RAS-Driven Cancers

UNIFI®, Makers of REPREVE®, Schedules Fourth Quarter Fiscal 2026 Earnings Conference Call

Financial Statements and Related Announcement: First Quarter Results

Change - Change in Corporate Information: Announcement pursuant to Rule 706A of the Listing Manual of the SGX-ST

Asset Acquisitions and Disposals: Announcement pursuant to Rule 706A of the SGX-ST Listing Manual

Mandatory Cash Dividend/ Distribution:

Financial Statements and Related Announcement: Half Yearly Results